Ordinary Index Rebalancing in the Solactive AKTIONR China Biotech AR Index | March 2022

In the ordinary rebalance the following composition will be implemented effective open 01.04.2022:

3SBIO INC
BEIGENE LTD-ADR
CSPC PHARMACEUTICAL GROUP LTD
FIBROGEN INC
GENSCRIPT BIOTECH CORP
HUTCHISON CHINA MEDITECH-ADR
LEES PHARMACEUTICAL HLDGS
LIVZON PHARMACEUTICAL GROUP INC
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD
SINO BIOPHARMACEUTICAL LTD ORD
SINOPHARM GROUP CO LTD
WUXI BIOLOGICS CAYMAN INC
YICHANG HEC CHANGJIANG PHA-H
ZAI LAB LTD